Cue Biopharma (NASDAQ: CUE)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Cue Biopharma (NASDAQ: CUE) through any online brokerage.
The latest price target for Cue Biopharma (NASDAQ: CUE) was reported by Oppenheimer on Monday, March 21, 2022. The analyst firm set a price target for 26.00 expecting CUE to rise to within 12 months (a possible 687.88% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Cue Biopharma (NASDAQ: CUE) is $3.3 last updated May 20, 2022, 8:00 PM UTC.
There are no upcoming dividends for Cue Biopharma.
Cue Biopharma’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Cue Biopharma.
Cue Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.